Structure and mechanism of styrene monooxygenase reductase: new insight into the FAD-transfer reaction E Morrison, A Kantz, GT Gassner, MH Sazinsky Biochemistry 52 (35), 6063-6075, 2013 | 63 | 2013 |
Quantitative analysis of the human T cell palmitome. E Morrison, B Kuropka, S Kliche, B Brügger, E Krause, C Freund Scientific reports 5, 11598-11598, 2015 | 47 | 2015 |
Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease DA Rider, M Eisermann, K Löffler, M Aleku, DI Swerdlow, S Dames, ... Atherosclerosis 349, 240-247, 2022 | 46 | 2022 |
Quantification of HLA-DM-dependent major histocompatibility complex of class II immunopeptidomes by the peptide landscape antigenic epitope alignment utility M Álvaro-Benito, E Morrison, ET Abualrous, B Kuropka, C Freund Frontiers in immunology 9, 872, 2018 | 43 | 2018 |
Human leukocyte Antigen-DM polymorphisms in autoimmune diseases M Alvaro-Benito, E Morrison, M Wieczorek, J Sticht, C Freund Open biology 6 (8), 160165, 2016 | 38 | 2016 |
Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4+ T cell activation M Álvaro-Benito, E Morrison, F Ebner, ET Abualrous, M Urbicht, ... Cellular & Molecular Immunology 17 (2), 133-142, 2020 | 25 | 2020 |
Dynamic palmitoylation events following T-cell receptor signaling E Morrison, T Wegner, AE Zucchetti, M Álvaro-Benito, A Zheng, S Kliche, ... Communications biology 3 (1), 368, 2020 | 23 | 2020 |
Splicing-accessible coding 3′ UTRs control protein stability and interaction networks M Preussner, Q Gao, E Morrison, O Herdt, F Finkernagel, M Schumann, ... Genome biology 21, 1-24, 2020 | 19 | 2020 |
Human hepatitis B viral infection outcomes are linked to naturally occurring variants of HLA-DOA that have altered function AM Graves, F Virdis, E Morrison, M Álvaro-Benito, AA Khan, C Freund, ... The Journal of Immunology 205 (4), 923-935, 2020 | 12 | 2020 |
Preclinical toxicological assessment of a novel siRNA, SLN360, targeting elevated Lipoprotein (a) in Cardiovascular Disease D Rider, S Chivers, J Aretz, M Eisermann, K Löffler, J Hauptmann, ... Toxicological Sciences 189 (2), 237-249, 2022 | 8 | 2022 |
CD4+ Th immunogenicity of the Ascaris spp. secreted products F Ebner, E Morrison, M Bertazzon, A Midha, S Hartmann, C Freund, ... NPJ vaccines 5 (1), 25, 2020 | 8 | 2020 |
NS1‐mediated upregulation of ZDHHC22 acyltransferase in influenza a virus infected cells MR Gadalla, E Morrison, MV Serebryakova, X Han, T Wolff, C Freund, ... Cellular Microbiology 23 (6), e13322, 2021 | 6 | 2021 |
The guanine-nucleotide exchange factor CalDAG GEFI fine-tunes functional properties of regulatory T cells J Niemz, S Kliche, MC Pils, E Morrison, A Manns, C Freund, JR Crittenden, ... European Journal of Microbiology and Immunology 7 (2), 112-126, 2017 | 4 | 2017 |
Pre-clinical Safety Assessment of SLN360, a Novel Short Interfering Ribonucleic Acid Targeting LPA D Rider, D Swerdlow, M Eisermann, K Loeffler, J Hauptmann, E Morrison, ... Circulation 142 (Suppl_3), A14720-A14720, 2020 | 3 | 2020 |
Nucleic acids for inhibiting expression of PROS1 in a cell U Schaeper, S Dames, E Morrison, RP ELADNANI, A Angelillo-Scherrer US Patent 11,820,971, 2023 | 2 | 2023 |
Nucleic acids for inhibiting expression of pros1 in a cell U Schaeper, S Dames, E Morrison, RP ELADNANI, A Angelillo-Scherrer US Patent App. 17/524,323, 2022 | 1 | 2022 |
CD4+ T Cell Epitope Identification from Complex Parasite Antigen Mixtures M Álvaro-Benito, F Ebner, M Bertazzon, E Morrison Computational Vaccine Design, 89-109, 2023 | | 2023 |
Nucleic acids for inhibiting expression of complement factor b (cfb) in a cell S Dames, E Morrison, V Aumiller, T Johanssen, S Rathjen, S Schubert WO Patent WO2023031359A1, 2023 | | 2023 |
Nucleic acids for inhibiting expression of xdh in a cell S Dames, E Morrison, V Aumiller, D Rider, T Johannssen, S Schubert, ... WO Patent WO2022223557A1, 2022 | | 2022 |
Natural variation of non-classical HLA class II: Should we care? M Alvaro-Benito, E Morrison, VF de Lima HLA 99 (5), 544-544, 2022 | | 2022 |